Wenhui Xie
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies 33
- Systemic Lupus Erythematosus Research 20
- Spondyloarthritis Studies and Treatments 8
- Hepatology top 5%
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis 7
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 9
- Epidemiology top 10%
-
- Chronic Lymphocytic Leukemia Research 15
- Inflammatory Bowel Disease 11
-
- Lymphoma Diagnosis and Treatment 6
- Cited by
- RheumatologyHepatologyImmunology
- Journals
- The American Journal of Medicine (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)BMJ (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Wenhui Xie
80 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Rheumatology 533
- Hepatology 185
- Immunology 317
- Hematology 127
- Epidemiology 321
Countries citing papers authored by Wenhui Xie
This map shows the geographic impact of Wenhui Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhui Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhui Xie more than expected).
Fields of papers citing papers by Wenhui Xie
This network shows the impact of papers produced by Wenhui Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhui Xie. The network helps show where Wenhui Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenhui Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 16 | |
| 11 | 2021 | 23 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 8 | |
| 14 | 2020 | 82 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 2 | |
| 17 | 2019 | 8 | |
| 18 | 2019 | 5 | |
| 19 | Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016. | 2018 | 14 |
| 20 | 2017 | 11 |
About Wenhui Xie
Wenhui Xie is a scholar working on Rheumatology, Genetics and Immunology, having authored 93 papers that have together received 1.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (33 papers), Systemic Lupus Erythematosus Research (20 papers), Chronic Lymphocytic Leukemia Research (15 papers), Inflammatory Bowel Disease (11 papers), Autoimmune and Inflammatory Disorders Research (9 papers), Spondyloarthritis Studies and Treatments (8 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Rheumatology (533 citations), Hepatology (185 citations) and Immunology (317 citations). Wenhui Xie has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Zhuoli Zhang, Shiyu Xiao, Yong Fan, Lanlan Ji, Hong Huang, Xiaoying Sun, Xuerong Deng, Guangtao Li, Yan Geng and Dai Gao. Their work appears in journals such as The American Journal of Medicine, Arteriosclerosis Thrombosis and Vascular Biology and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.